Assessment of fracture risk in women with breast cancer using current vs emerging guidelines

BACKGROUND: Breast cancer (BC) therapies can have negative effects on bone. Current guidelines recommend antiresorptive therapy based on bone mineral density (BMD), and emerging guidelines include both clinical risk factors and BMD to assess the overall fracture risk. A retrospective, case–controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadji, P, Ziller, M, Albert, U S, Kalder, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837568/
https://www.ncbi.nlm.nih.gov/pubmed/20087347
http://dx.doi.org/10.1038/sj.bjc.6605548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837568/
https://www.ncbi.nlm.nih.gov/pubmed/20087347
http://dx.doi.org/10.1038/sj.bjc.6605548

Ejemplares similares